Researchers Create Embryonic Stem Cells Without Embryo

Discovery of a novel reprogramming method of adult cells could shift stem cell research.

Written byLori J. Schroth, Brigham and Women’s Hospital Communications
| 4 min read
Register for free to listen to this article
Listen with Speechify
0:00
4:00

Since the discovery of human embryonic stem cells, scientists have had high hopes for their use in treating a wider variety of diseases because they are “pluripotent,” which means they are capable of differentiating into one of many cell types in the body.

However, the acquisition of human embryonic stem cells from an embryo can cause the destruction of the embryo, thus raising ethical concerns. In 2006, researchers introduced an alternative to harvesting embryonic stem cells called induced pluripotent stem (iPS) cells. They provided evidence that it was possible to send a normal adult cell back to an undifferentiated, pluripotent stem cell state by introducing genetic material (“outside” DNA) into the cell, a process that alters the original state of the cell.

To avoid the use of embryonic stem cells, other researchers have focused more on the use of adult stem cells, but the use of these cells is limited because, unlike embryonic stem cells that grow into any type of mature cell, adult stem cells can only grow into certain cell types.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

CURRENT ISSUE - March/2026

When the Unexpected Hits

How Lab Leaders Can Prepare for Safety Crises That Don’t Follow the Script

Lab Manager March 2026 Cover Image